HomeCompareUNCRY vs PFE

UNCRY vs PFE: Dividend Comparison 2026

UNCRY yields 4.40% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UNCRY wins by $3006.76M in total portfolio value
10 years
UNCRY
UNCRY
● Live price
4.40%
Share price
$33.95
Annual div
$1.49
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3006.81M
Annual income
$2,880,905,006.62
Full UNCRY calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — UNCRY vs PFE

📍 UNCRY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUNCRYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UNCRY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UNCRY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UNCRY
Annual income on $10K today (after 15% tax)
$373.64/yr
After 10yr DRIP, annual income (after tax)
$2,448,769,255.63/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, UNCRY beats the other by $2,448,746,126.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UNCRY + PFE for your $10,000?

UNCRY: 50%PFE: 50%
100% PFE50/50100% UNCRY
Portfolio after 10yr
$1503.43M
Annual income
$1,440,466,108.58/yr
Blended yield
95.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

UNCRY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.3
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UNCRY buys
0
PFE buys
0
No recent congressional trades found for UNCRY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUNCRYPFE
Forward yield4.40%6.20%
Annual dividend / share$1.49$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$3006.81M$51.1K
Annual income after 10y$2,880,905,006.62$27,210.54
Total dividends collected$2997.88M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: UNCRY vs PFE ($10,000, DRIP)

YearUNCRY PortfolioUNCRY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,579$879.15$9,161$701.38+$2.4KUNCRY
2$14,292$1,902.78$8,610$859.79+$5.7KUNCRY
3$19,683$4,390.00$8,366$1,081.25+$11.3KUNCRY
4$32,361$11,300.40$8,483$1,405.66+$23.9KUNCRY
5$69,354$34,727.53$9,084$1,907.24+$60.3KUNCRY
6$213,322$139,112.92$10,418$2,732.78+$202.9KUNCRY
7$1,028,047$799,792.45$13,007$4,193.56+$1.02MUNCRY
8$8,304,469$7,204,458.94$18,010$7,005.87+$8.29MUNCRY
9$117,665,175$108,779,393.64$28,216$12,979.89+$117.64MUNCRY
10$3,006,806,744$2,880,905,006.62$51,081$27,210.54+$3006.76MUNCRY

UNCRY vs PFE: Complete Analysis 2026

UNCRYStock

UniCredit S.p.A. operates as a commercial bank that provides retail, corporate, and private banking services. It offers accounts and deposits, loans, cards, transactions and payments, funds, advisory, treasury, and insurance products, as well as digital and mobile banking services. The company also provides solutions for payments and liquidity, working capital, hedging, international trade, and treasury operations; and funding solutions comprising of structured, project, and commodity trade and export finance, as well as debt and equity funding; and structured investments and investments advisory solutions. In addition, the company provides corporate finance, capital structure, and rating advisory, as well as patient capital, financial sponsor solutions, and sustainable finance solutions. It servs retail, corporate, and public sector customers, as well as international companies and institutional clients. The company operates in Italy, Other European countries, America, Asia, and internationally. The company was formerly known as Unicredito Italiano S.p.A and changed its name to UniCredit S.p.A. UniCredit S.p.A. was founded in 1870 and is headquartered in Milan, Italy.

Full UNCRY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this UNCRY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UNCRY vs SCHDUNCRY vs JEPIUNCRY vs OUNCRY vs KOUNCRY vs MAINUNCRY vs JNJUNCRY vs MRKUNCRY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.